InsiderTrades.com logo

TERN Insider Trading

Insider Ownership Percentage: 15.10%
Insider Buying (Last 12 Months): $5,124,566.10
Insider Selling (Last 12 Months): $1,052,698.51

Terns Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Terns Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Terns Pharmaceuticals Share Price & Price History

Current Price: $2.41
Price Change: ▲ Price Increase of +0.165 (7.37%)
As of 04/17/2025 04:59 PM ET

This chart shows the closing price history over time for TERN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Terns Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/1/2025Emil KuriakoseInsiderSell952$2.49$2,370.4853,317View SEC Filing Icon  
1/6/2025Jill M. QuigleyDirectorSell8,760$5.79$50,720.40View SEC Filing Icon  
1/6/2025Mark J VignolaCFOSell9,059$5.80$52,542.2074,752View SEC Filing Icon  
1/2/2025Emil KuriakoseInsiderSell4,481$5.71$25,586.5154,269View SEC Filing Icon  
1/2/2025Jill M QuigleyDirectorSell6,240$5.72$35,692.808,760View SEC Filing Icon  
1/2/2025Mark J VignolaCFOSell8,129$5.72$46,497.8883,811View SEC Filing Icon  
12/5/2024Amy L BurroughsCEOBuy15,450$7.15$110,467.5019,099View SEC Filing Icon  
11/30/2024Amy L BurroughsCEOBuy510$5.11$2,606.1019,609View SEC Filing Icon  
11/30/2024Melita Sun JungInsiderBuy2,250$5.11$11,497.502,250View SEC Filing Icon  
9/12/2024Hongbo LuDirectorBuy476,190$10.50$4,999,995.00476,190View SEC Filing Icon  
9/10/2024Mark J VignolaCFOSell10,000$11.00$110,000.0091,940View SEC Filing Icon  
9/9/2024Jill M QuigleyDirectorSell17,235$10.00$172,350.0015,000View SEC Filing Icon  
8/1/2024Jill M QuigleyDirectorSell6,143$7.68$47,178.2423,857View SEC Filing Icon  
7/15/2024Carl L GordonDirectorSell50,976$10.00$509,760.00756,258View SEC Filing Icon  
4/3/2024Vivo Opportunity, LlcMajor ShareholderSell138,066$6.20$856,009.20268,573View SEC Filing Icon  
4/1/2024Vivo Opportunity, LlcMajor ShareholderSell181,117$6.99$1,266,007.83275,772View SEC Filing Icon  
12/23/2022Orbimed Advisors LlcDirectorBuy137,931$7.25$999,999.754,882,854View SEC Filing Icon  
12/23/2022Vivo Opportunity, LlcMajor ShareholderBuy758,620$7.25$5,499,995.004,340,212View SEC Filing Icon  
11/23/2022Biosciences Fund V L.P. LavMajor ShareholderSell1,500,000$5.50$8,250,000.00405,583View SEC Filing Icon  
9/7/2022Vivo Opportunity, LlcMajor ShareholderBuy600,000$3.60$2,160,000.003,581,592View SEC Filing Icon  
8/16/2022Hongbo LuDirectorBuy1,500,000$2.42$3,630,000.002,981,592View SEC Filing Icon  
8/15/2022Vivo Opportunity, LlcMajor ShareholderBuy1,218$2.99$3,641.821,481,592View SEC Filing Icon  
8/12/2022Vivo Opportunity, LlcMajor ShareholderBuy1,123,021$2.98$3,346,602.581,480,374View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Terns Pharmaceuticals (NASDAQ:TERN)

98.26% of Terns Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TERN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Terns Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/17/2025Exchange Traded Concepts LLC137,663$0.38M0.0%-3.7%0.158%Search for SEC Filing on Google Icon
4/15/2025SG Americas Securities LLC413,822$1.14M0.0%+1,141.5%0.474%Search for SEC Filing on Google Icon
4/11/2025E. Ohman J or Asset Management AB102,410$0.28M0.0%+27.4%0.117%Search for SEC Filing on Google Icon
4/10/2025Thrive Wealth Management LLC10,500$29K0.0%N/A0.012%Search for SEC Filing on Google Icon
2/26/2025Infinitum Asset Management LLC200,000$1.11M0.6%N/A0.235%Search for SEC Filing on Google Icon
2/17/2025Voloridge Investment Management LLC59,720$0.33M0.0%-62.2%0.070%Search for SEC Filing on Google Icon
2/17/2025VR Adviser LLC1,077,090$5.97M0.4%-68.4%1.268%Search for SEC Filing on Google Icon
2/17/2025Woodline Partners LP311,612$1.73M0.0%+3.4%0.367%Search for SEC Filing on Google Icon
2/17/2025Velan Capital Investment Management LP17,000$94K0.1%N/A0.020%Search for SEC Filing on Google Icon
2/17/2025Soleus Capital Management L.P.8,142,500$45.11M2.8%+30.8%9.586%Search for SEC Filing on Google Icon
2/17/2025Squarepoint Ops LLC13,125$73K0.0%-75.5%0.015%Search for SEC Filing on Google Icon
2/17/2025Two Sigma Investments LP94,689$0.53M0.0%-34.4%0.111%Search for SEC Filing on Google Icon
2/17/2025Tema Etfs LLC79,696$0.44M0.2%N/A0.094%Search for SEC Filing on Google Icon
2/17/2025Sherbrooke Park Advisers LLC17,846$99K0.0%N/A0.021%Search for SEC Filing on Google Icon
2/17/2025Point72 Asset Management L.P.1,251,841$6.94M0.0%-53.8%1.474%Search for SEC Filing on Google Icon
2/17/2025ProShare Advisors LLC23,821$0.13M0.0%+58.4%0.028%Search for SEC Filing on Google Icon
2/17/2025Parkman Healthcare Partners LLC829,105$4.59M0.6%+51.9%0.976%Search for SEC Filing on Google Icon
2/17/2025Nuveen Asset Management LLC2,633,918$14.59M0.0%+30.6%3.101%Search for SEC Filing on Google Icon
2/17/2025OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC 140,300$0.78M0.1%+192.3%0.165%Search for SEC Filing on Google Icon
2/17/2025Millennium Management LLC1,610,215$8.92M0.0%-1.1%1.896%Search for SEC Filing on Google Icon
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.39,784$0.22M0.0%+26.2%0.047%Search for SEC Filing on Google Icon
2/17/2025Integral Health Asset Management LLC450,000$2.49M0.2%+50.0%0.530%Search for SEC Filing on Google Icon
2/17/2025J. Goldman & Co LP235,831$1.31M0.0%+15.6%0.278%Search for SEC Filing on Google Icon
2/17/2025Graham Capital Management L.P.132,999$0.74M0.0%+897.1%0.157%Search for SEC Filing on Google Icon
2/17/2025D. E. Shaw & Co. Inc.57,341$0.32M0.0%+53.0%0.068%Search for SEC Filing on Google Icon
2/17/2025Deutsche Bank AG398,379$2.21M0.0%-26.6%0.469%Search for SEC Filing on Google Icon
2/17/2025Driehaus Capital Management LLC1,661,846$9.21M0.1%-20.6%1.956%Search for SEC Filing on Google Icon
2/17/2025Crestline Management LP66,599$0.37M0.0%N/A0.078%Search for SEC Filing on Google Icon
2/17/2025Cubist Systematic Strategies LLC11,964$66K0.0%-93.6%0.014%Search for SEC Filing on Google Icon
2/17/2025Bank of America Corp DE197,226$1.09M0.0%+236.8%0.232%Search for SEC Filing on Google Icon
2/17/2025Bellevue Group AG1,061,753$5.88M0.1%+1.9%1.250%Search for SEC Filing on Google Icon
2/17/2025BNP Paribas Financial Markets224,265$1.24M0.0%N/A0.264%Search for SEC Filing on Google Icon
2/17/2025Acorn Capital Advisors LLC1,971,264$10.92M6.0%N/A2.321%Search for SEC Filing on Google Icon
2/17/2025Acuta Capital Partners LLC447,500$2.48M2.5%-8.1%0.527%Search for SEC Filing on Google Icon
2/14/2025Boxer Capital Management LLC752,000$4.17M0.4%N/A0.885%Search for SEC Filing on Google Icon
2/14/2025Schonfeld Strategic Advisors LLC4,751,506$26.32M0.2%+44.4%5.594%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp591,171$3.28M0.0%+27.4%0.696%Search for SEC Filing on Google Icon
2/14/2025The Manufacturers Life Insurance Company 24,378$0.14M0.0%-63.1%0.029%Search for SEC Filing on Google Icon
2/14/2025Oxford Asset Management LLP15,456$86K0.0%N/A0.018%Search for SEC Filing on Google Icon
2/14/2025Nebula Research & Development LLC25,849$0.14M0.0%+128.2%0.030%Search for SEC Filing on Google Icon
2/14/2025Price T Rowe Associates Inc. MD1,504,238$8.34M0.0%+1.9%1.771%Search for SEC Filing on Google Icon
2/14/2025Diadema Partners LP50,370$0.28M0.1%N/A0.059%Search for SEC Filing on Google Icon
2/14/2025Hsbc Holdings PLC35,898$0.20M0.0%+216.1%0.042%Search for SEC Filing on Google Icon
2/14/2025MetLife Investment Management LLC43,760$0.24M0.0%+27.7%0.052%Search for SEC Filing on Google Icon
2/14/2025Dimensional Fund Advisors LP1,302,932$7.22M0.0%+107.0%1.534%Search for SEC Filing on Google Icon
2/14/2025Altium Capital Management LLC475,000$2.63M0.7%+43.9%0.559%Search for SEC Filing on Google Icon
2/13/2025Marshall Wace LLP803,336$4.45M0.0%+666.8%0.946%Search for SEC Filing on Google Icon
2/13/2025Jump Financial LLC62,401$0.35M0.0%+52.2%0.073%Search for SEC Filing on Google Icon
2/13/2025Walleye Capital LLC118,896$0.66M0.0%-36.0%0.140%Search for SEC Filing on Google Icon
2/13/2025Barclays PLC704,371$3.90M0.0%+444.7%0.829%Search for SEC Filing on Google Icon
2/13/2025Townsquare Capital LLC13,809$76K0.0%N/A0.016%Search for SEC Filing on Google Icon
2/13/2025Martingale Asset Management L P98,106$0.54M0.0%+32.4%0.116%Search for SEC Filing on Google Icon
2/13/2025Renaissance Technologies LLC623,134$3.45M0.0%+30.0%0.734%Search for SEC Filing on Google Icon
2/13/2025Invesco Ltd.23,400$0.13M0.0%+13.3%0.028%Search for SEC Filing on Google Icon
2/13/2025Polymer Capital Management HK LTD177,000$0.98M0.2%+637.5%0.208%Search for SEC Filing on Google Icon
2/13/2025Russell Investments Group Ltd.628,395$3.48M0.0%-15.6%0.740%Search for SEC Filing on Google Icon
2/13/2025Wells Fargo & Company MN40,966$0.23M0.0%+56.8%0.048%Search for SEC Filing on Google Icon
2/12/2025Landscape Capital Management L.L.C.13,196$73K0.0%N/A0.016%Search for SEC Filing on Google Icon
2/12/2025ExodusPoint Capital Management LP10,816$60K0.0%-99.3%0.013%Search for SEC Filing on Google Icon
2/12/2025Cinctive Capital Management LP109,997$0.61M0.0%-34.7%0.130%Search for SEC Filing on Google Icon
2/12/2025Trexquant Investment LP253,247$1.40M0.0%-16.7%0.298%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC1,516,478$8.40M0.0%+25.6%1.785%Search for SEC Filing on Google Icon
2/12/2025Alliancebernstein L.P.362,359$2.01M0.0%+48.2%0.427%Search for SEC Filing on Google Icon
2/12/2025Orion Portfolio Solutions LLC22,211$0.12M0.0%N/A0.026%Search for SEC Filing on Google Icon
2/12/2025Norges Bank849,389$4.71M0.0%N/A1.000%Search for SEC Filing on Google Icon
2/12/2025NEOS Investment Management LLC79,696$0.44M0.0%-37.9%0.094%Search for SEC Filing on Google Icon
2/12/2025JPMorgan Chase & Co.51,830$0.29M0.0%-70.4%0.061%Search for SEC Filing on Google Icon
2/11/2025EntryPoint Capital LLC60,388$0.34M0.1%N/A0.071%Search for SEC Filing on Google Icon
2/11/2025Corebridge Financial Inc.34,951$0.19M0.0%+13.5%0.041%Search for SEC Filing on Google Icon
2/11/2025Vanguard Group Inc.3,869,582$21.44M0.0%+15.3%4.556%Search for SEC Filing on Google Icon
2/11/2025LPL Financial LLC252,325$1.40M0.0%+397.2%0.297%Search for SEC Filing on Google Icon
2/11/2025American Century Companies Inc.113,225$0.63M0.0%+33.4%0.133%Search for SEC Filing on Google Icon
2/10/2025Connor Clark & Lunn Investment Management Ltd.74,858$0.42M0.0%+41.2%0.088%Search for SEC Filing on Google Icon
2/7/2025HighTower Advisors LLC84,430$0.47M0.0%N/A0.099%Search for SEC Filing on Google Icon
2/7/2025Candriam S.C.A.2,153,969$11.93M0.1%N/A2.536%Search for SEC Filing on Google Icon
2/6/2025Charles Schwab Investment Management Inc.206,450$1.14M0.0%+33.4%0.243%Search for SEC Filing on Google Icon
2/4/2025Bank of New York Mellon Corp186,308$1.03M0.0%+15.4%0.219%Search for SEC Filing on Google Icon
2/4/2025Y Intercept Hong Kong Ltd67,002$0.37M0.0%+84.1%0.079%Search for SEC Filing on Google Icon
1/30/2025Rhumbline Advisers97,892$0.54M0.0%+16.0%0.115%Search for SEC Filing on Google Icon
1/29/2025Savant Capital LLC16,083$89K0.0%N/A0.019%Search for SEC Filing on Google Icon
1/28/2025Stoneridge Investment Partners LLC20,603$0.11M0.0%N/A0.024%Search for SEC Filing on Google Icon
1/27/2025Bleakley Financial Group LLC48,296$0.27M0.0%+262.8%0.057%Search for SEC Filing on Google Icon
1/27/2025E. Ohman J or Asset Management AB80,378$0.45M0.0%+30.1%0.095%Search for SEC Filing on Google Icon
1/24/2025China Universal Asset Management Co. Ltd.18,010$100K0.0%+33.1%0.021%Search for SEC Filing on Google Icon
1/21/2025Exchange Traded Concepts LLC142,919$0.79M0.0%+34.1%0.168%Search for SEC Filing on Google Icon
1/17/2025SG Americas Securities LLC33,333$0.19M0.0%+40.0%0.039%Search for SEC Filing on Google Icon
1/13/2025Salem Investment Counselors Inc.346,725$1.92M0.1%-7.9%0.408%Search for SEC Filing on Google Icon
11/20/2024Virtu Financial LLC62,216$0.52M0.0%+110.2%0.073%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC1,207,479$10.07M0.0%+7.6%1.422%Search for SEC Filing on Google Icon
11/15/2024Y Intercept Hong Kong Ltd36,392$0.30M0.0%-42.7%0.043%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd17,696$0.15M0.0%N/A0.021%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP222,065$1.85M0.0%-0.9%0.261%Search for SEC Filing on Google Icon
11/15/2024State Street Corp1,116,991$9.32M0.0%-5.1%1.315%Search for SEC Filing on Google Icon
11/15/2024Point72 Asset Management L.P.2,707,515$22.58M0.1%+0.6%3.188%Search for SEC Filing on Google Icon
11/15/2024Polymer Capital Management HK LTD24,000$0.20M0.0%N/A0.028%Search for SEC Filing on Google Icon
11/15/2024Parkman Healthcare Partners LLC545,751$4.55M0.6%+39.8%0.643%Search for SEC Filing on Google Icon
11/15/2024Ikarian Capital LLC308,497$2.57M0.3%-32.7%0.363%Search for SEC Filing on Google Icon
11/15/2024HighVista Strategies LLC130,966$1.09M0.4%-11.6%0.154%Search for SEC Filing on Google Icon
11/15/2024Cinctive Capital Management LP168,564$1.41M0.1%N/A0.198%Search for SEC Filing on Google Icon
11/14/2024Bellevue Group AG1,042,135$8.69M0.1%N/A1.482%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Terns Pharmaceuticals logo
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology, metabolic dysfunction-associated steatohepatitis (MASH), and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of MASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.
Read More on Terns Pharmaceuticals

Today's Range

Now: $2.41
Low: $2.23
High: $2.44

50 Day Range

MA: $3.19
Low: $2.00
High: $4.34

52 Week Range

Now: $2.41
Low: $1.87
High: $11.40

Volume

891,657 shs

Average Volume

1,510,924 shs

Market Capitalization

$209.95 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Terns Pharmaceuticals?

Terns Pharmaceuticals' top insider shareholders include:
  1. Carl L Gordon (Director)
  2. Hongbo Lu (Director)
  3. Vivo Opportunity, Llc (Major Shareholder)
  4. Mark J Vignola (CFO)
  5. Emil Kuriakose (Insider)
  6. Jill M Quigley (Director)
  7. Amy L Burroughs (CEO)
  8. Melita Sun Jung (Insider)
  9. Jill M Quigley (Director)
Learn More about top insider investors at Terns Pharmaceuticals.

Who are the major institutional investors of Terns Pharmaceuticals?

Terns Pharmaceuticals' top institutional shareholders include:
  1. SG Americas Securities LLC — 0.47%
  2. Exchange Traded Concepts LLC — 0.16%
  3. E. Ohman J or Asset Management AB — 0.12%
  4. Thrive Wealth Management LLC — 0.01%
Learn More about top institutional investors of Terns Pharmaceuticals stock.

Which institutional investors are selling Terns Pharmaceuticals stock?

Within the last quarter, TERN stock was sold by these institutional investors:
  1. Exchange Traded Concepts LLC
Within the last year, company insiders that have sold Terns Pharmaceuticals company stock include:
  1. Carl L Gordon (Director)
  2. Hongbo Lu (Director)
  3. Vivo Opportunity, Llc (Major Shareholder)
  4. Mark J Vignola (CFO)
  5. Emil Kuriakose (Insider)
Learn More investors selling Terns Pharmaceuticals stock.

Which institutional investors are buying Terns Pharmaceuticals stock?

In the previous quarter, TERN stock was acquired by institutional investors including:
  1. SG Americas Securities LLC
  2. E. Ohman J or Asset Management AB
  3. Thrive Wealth Management LLC
During the last year, these company insiders have bought Terns Pharmaceuticals stock:
  1. Carl L Gordon (Director)
  2. Hongbo Lu (Director)
  3. Vivo Opportunity, Llc (Major Shareholder)
Learn More investors buying Terns Pharmaceuticals stock.